CD8+ cells (potentially cytotoxic T lymphocytes) in the tumor center were generally scarce (<100 cells/HPF) and did not show significant differences between both patient groups neither at the invasive margin nor the tumor center (Figures 6C,D). This evidence concerns the gene CD8A and neoplasm.